Hi °C | Lo °C Chief executive: Alan Armstrong
Employment: 2,638
Turnover: £251m
Pre-tax profit: £14.4m
Craigavon-based Almac provides a range of integrated drug development services to the pharmaceutical and biotech industry.
Despite the ongoing economic slowdown, Almac’s global turnover has increased in the past year by 12% to £251m. During the same period their employment increased by 13.4% and now stands at 2,838.
Almac’s new $120m North American HQ is now fully operational.
The 240,000 sq ft facility houses its clinical services and and clinical technologies divisions as well as an extensive analytical suite. In Craigavon, work has commenced on a new £3m three-storey facility that will accommodate 225 staff.
January marked a year since the death of the company’s inspirational chairman Sir Allen McClay. He founded Almac in 2000, buying five divisions from his former venture Galen, in order to keep jobs in Northern Ireland.
Almac works with all the major pharmaceutical companies, hundreds of biotechs and now sends product to more than 100 countries worldwide.
Contact Us
Almac House,
Seagoe Industrial Estate,
Craigavon,
BT63 5QD
Tel: 028 3833 2200
